Section Review Biologicals & Immunologicals: Advances in antibody engineering
- 1 May 1996
- journal article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 6 (5) , 441-456
- https://doi.org/10.1517/13543776.6.5.441
Abstract
Our ability to genetically modify antibody molecules has been dramatically enhanced by a number of technological breakthroughs, including the ability to rapidly and easily clone the variable region genes, and the development of good expression systems. In addition phage display technology has given a new impetus to the field by allowing the isolation and modification of novel antibodies. This paper reviews these important areas, and describes some of the more common genetic constructs that have been produced. Such recombinant molecules are entering clinical trials more frequently and will become increasingly important as diagnostic and therapeutic agents.Keywords
This publication has 74 references indexed in Scilit:
- Calmodulin as a Versatile Tag for Antibody FragmentsNature Biotechnology, 1995
- Applications of monoclonal antibodies in clinical oncologyImmunology Today, 1994
- Selection of Phage-displayed Antibodies Specific for a Cytoskeletal Antigen by Competitive Elution with a Monoclonal AntibodyJournal of Molecular Biology, 1994
- ‘Camelising’ human antibody fragments: NMR studies on VH domainsFEBS Letters, 1994
- Cloning, sequencing and expression of the Fab fragment of a monoclonal antibody to the herbicide atrazineProtein Engineering, Design and Selection, 1993
- Antibody framework residues affecting the conformation of the hypervariable loopsJournal of Molecular Biology, 1992
- Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coliBiochemistry, 1991
- A reliable method for random mutagenesis: the generation of mutant libraries using spiked oligodeoxyribonucleotide primersGene, 1989
- Production of antibodies in transgenic plantsNature, 1989
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986